WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List Reform ... The NHSA has released for public consultation a set of draft policy documents outlining the 2025 adjustment framework for the NRDL and a separate list for commercial heal...
(7/1/2025)

Analysing Key Trends In China's Patent-linkage... (7/12/2025)

China's Rising Biotechnology Sector: Friend or... (7/10/2025)

As Chinese-developed Drugs Draw U.S. Interest,... (7/8/2025)

FDA's Crackdown and China's Dealmaking: Warnin... (7/2/2025)

Medical Advances Soar With APAC's Clinical Tri... (7/2/2025)

Tracking the Crossroads of Policy, Innovation,... (7/1/2025)

BeOne Launches Phase III Trial Comparing Subcu... (7/1/2025)

China Launches Landmark Measures to Boost Inno... (7/1/2025)

Analyzing Key Trends in China's Patent-Linkage... (6/27/2025)

Fresh Antitrust Guidelines to Address Pharmace... (6/27/2025)

Breaking the Boundaries: A New Map of Physicia... (6/25/2025)

Structuring Cross Border China Biotech 'NewCo'... (6/19/2025)

Recent Official and Execut... (7/12/2025) China's First 9-Valent HPV Vaccine Launc... (7/12/2025) Flamma Opens New cGMP Plant in Dalian (7/12/2025) Vice Premier Urges Stronger Focus on Ba... (7/11/2025) Evopoint's CLDN18.2‑Targeting ADC XNW27... (7/11/2025) Regenelead's KRAS-Targeted Cancer Vaccin... (7/11/2025) Biocytogen Strengthens Ties with BeOne T... (7/11/2025) TandemAI and Perpetual Medicine Announce... (7/11/2025) Haleon Secures Full Ownership of Tianjin... (7/11/2025) BeOne's Tevimbra Wins EU Green Light for... (7/11/2025) China's NHSA Unveils 2025 Drug Directory... (7/11/2025) China Issues 2nd Batch of Rare Disease C... (7/11/2025) Henlius Wins Global Regulatory Clearance... (7/10/2025) China Approves Three New Drugs for Cance... (7/10/2025) Sironax Grants Novartis Exclusive Option... (7/10/2025) China's Biopharma Licensing Deals Surge ... (7/10/2025) Simcere Advances Rademikibart with NDA S... (7/9/2025) China Struggles to Maintain Grip on Indi... (7/9/2025)

China Hospitals Prioritize Local Innovation, Digital He... China's Pharma Market Faces Mixed Performance in Q1 202... China's Retail Pharmacy Market Hits CNY 941.1B in 2024 ... NH's DB6: China's Consumer Healthcare Market Underperfo... China's Hospital Drug Market Shows Slight Growth in 202...

Flamma Opens New cGMP Plant in Dalian China's First 9-Valent HPV Vaccine Launches at 60% Disc... Haleon Secures Full Ownership of Tianjin Sino‑American... TandemAI and Perpetual Medicine Announce Strategic Merg... Biocytogen Strengthens Ties with BeOne Thru Expanded An...

China's NMPA Reopens Public Consultation on Revised Con... NMPA Releases 93rd Batch of Reference Formulations for ... CDE Seeks Comment on Revised eCTD Technical Documents a... CDE Solicits Comments on the 95th Batch of Reference Fo... China Issues Technical Guidance for Clinical Resistance...

China Issues 2nd Batch of Rare Disease Clinical Guideli... China's NHSA Unveils 2025 Drug Directory Revisions and ... NHSA Seeks Public Input on 2025 Drug Reimbursement and ... China Raises Per Capita Public Health Funding to Suppor... China Issues Guidelines to Promote TCM and Western Medi...

U.S. Lawmakers Raise Fresh Alarm Over GenScript's China... Record China Pharma Monopoly Fine Sends Strong Deterren... Conjupro Files USPTO Challenge on Ascletis' U.S. Patent... China's Draft National Medical Security Law: Seven Key ... China Releases Draft Medical Security Law for Public Co...

China Struggles to Maintain Grip on India's Bulk Drug M... API China 2025 Ends with High Attendance and Global Ind... FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi...

BeOne's Tevimbra Wins EU Green Light for First-Line Nas... Regenelead's KRAS-Targeted Cancer Vaccine Approved for ... Evopoint's CLDN18.2‑Targeting ADC XNW27011 Launches Fi... Henlius Wins Global Regulatory Clearance to Launch Phas... Hansoh Pharma Launches Phase 1 Trial of HS-20093 with A...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...